Disclaimer: Comprehensive human safety data for these peptides are limited
(December 2021)
Nebido takes a significant amount of time to reach stable levels due to its relatively long half-life, but at a dose of 125mg every week, we do ultimately reach stable levels with relatively small fluctuations between the peak and trough for daily release as shown below: Figure 15 Approximate average daily release of Testosterone at 125mg of Nebido every week If this methodology was to be adopted by the NHS or within private practice, a loading dose regime could improve the time taken to achieve stability
June 4, 2026 New Research from Merck Animal Health Reveals Hidden Parasitic Infections Cost Global Dairy Industry Billions Each Year May 4, 2026 In Observance of Mental Health Awareness Month, Merck Animal Health Announces Inaugural Veterinary Wellbeing Collective to Help Advance Veterinary Wellbeing March 18, 2026 FDA Approves BRAVECTO QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs February 25, 2026 FDA Approves NUMELVI (atinvicitinib tablets) for Dogs from Merck Animal Health The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis February 24, 2026 Merck Animal Health Wins 2025 S&P Global Award in Best Product and Best Product Companion Animal Food Animal Categories for NUMELVI and INNOVAX ND-IBD-ILT, Respectively December 4, 2025 FDA Conditionally Approves Merck Animal Healths EXZOLT CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis) November 4, 2025 Mexicos SADER Approves Merck Animal Healths EXZOLT 5% Pour-On (Fluralaner 50 mg/mL) for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (Myiasis) October 23, 2025 New Data from Merck Animal Health Demonstrates that Intranasal Vaccination Against Bovine Coronavirus with BOVILIS NASALGEN-C (Lyophilisate and Solvent for Suspension for Cattle) Significantly Improves Production in Veal Calves
Rodent trials showed 50% faster ligament recovery, with users at 500 mcg/day noting reduced joint pain and stronger lifts after 46 weeks, aiding long-term performance
